Skip to main content
. 2022 Dec 6;13:1079508. doi: 10.3389/fendo.2022.1079508

Figure 5.

Figure 5

Conversion ratio analysis of peripheral steroids based on ARMC5 status. Only significant conversion ratios are displayed. (A) Comparison of A/17OHP between wild-type ARMC5 patients and mutant ARMC5 patients. (B) Comparison of T/A between wild-type ARMC5 patients and mutant ARMC5 patients. A, androstenedione; 17OHP, 17-hydroxyprogesterone; T, testosterone. WT, wild-type ARMC5 patients; MUT, mutant ARMC5 patients. *p<0.05